Nakauchi C M, Linhares A C, Maruyama K, Kanzaki L I, Macedo J E, Azevedo V N, Casseb J S
Instituto Evandro Chagas, Fundação Serviços de Saúde Pública, Belém, PA, Brasil.
Mem Inst Oswaldo Cruz. 1990 Jan-Mar;85(1):29-33. doi: 10.1590/s0074-02761990000100004.
Forty-three (31.4%) out of 137 serum samples obtained from two Indian communities living in the Amazon region were found to be positive for HTLV-I antibody, as tested by enzyme-linked immunosorbent assay (ELISA). Eighty-two sera were collected from Mekranoiti Indians, yielding 39% of positivity, whereas 11 (20.0%) of the 55 Tiriyo serum samples had antibody to HTLV-I. In addition, positive results occurred in 10 (23.2%) out of 43 sera obtained from patients living in the Belem area, who were suffering from cancer affecting different organs. Five (16.7%) out of 30 ELISA positive specimens were also shown to be positive by either Western blot analysis (WB) or indirect immunogold electron microscopy (IIG-EM).
通过酶联免疫吸附测定（ELISA）检测发现，从生活在亚马逊地区的两个印度社区采集的137份血清样本中，有43份（31.4%）HTLV-I抗体呈阳性。从梅克拉诺伊蒂印第安人那里采集了82份血清，阳性率为39%，而55份蒂里尤血清样本中有11份（20.0%）含有抗HTLV-I抗体。此外，从贝伦地区患有不同器官癌症的患者那里采集的43份血清中，有10份（23.2%）检测结果呈阳性。30份ELISA阳性标本中有5份（16.7%）通过蛋白质印迹分析（WB）或间接免疫金电子显微镜检查（IIG-EM）也显示为阳性。
